Christian Milliet has over 25 years of experience in the pharma industry, leading Clinical Operations teams across Europe, USA, Latin America, China and Japan. His expertise encompasses all phases of drug development in a multitude of therapeutic areas.
He is currently Head of Site & Healthcare Ambassadors at CSL Behring. Previously, he worked for Vifor Pharma, Novartis, Serono and Covance.
In his current role, Christian is spearheading the development and expansion of site partnerships, leveraging CSL global presence. His focus is on creating strategic relationships to successfully deliver the CSL portfolio, including clinical development and real-world evidence.
Christian has a degree in Business Administration from Webster University in St. Louis, USA.
Stephanie is a Director in J&J’s Innovative Health Team, where she works to explore alternative options to traditional trial conduct in order to improve trial accessibility. Prior to joining Johnson & Johnson, she worked in Novartis’ Patient Experience team and spent 14 years as a management consultant with Accenture. American by birth, she has been living in Dublin, Ireland since 2016.
Deb Guattery most recently worked at Pfizer as the Process Lead for Home Health and Decentralized Clinical Trials. In that role, she built the processes and expanded the services of home nursing visits and other decentralized trial elements to be written into clinical trial protocols. Deb also advised in the writing of WCG Avoca Key Performance Indicators for the use of home health visits in a clinical trial and is an active participant in collaborative groups within the Decentralized Trials and Research Alliance (DTRA).
Deb continues to seek the advance of decentralized elements like the use of home health visits with the ultimate goal of driving better recruitment and retention of more diverse patients in clinical trials.
Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and a volunteer for the American Society of Clinical Oncology.
Joonmi has 15+ years of experience in medical imaging and its application to clinical research and clinical trials. She is leading quantitative analysis and QC department and governing AI on delivery and R&D at Clario. Her experience includes product development, imaging protocol design, image processing algorithm and operational imaging service development. Joonmi has a Ph.D. degree in Electronical Engineering from University of Birmingham, UK.
Kate is a category and shopper expert. During her five years at Diageo, Kate was a key driver of the success of the Alcohol-free growth in GB. She has been instrumental in championing the Alcohol-free agenda and her efforts have notably improved Alcohol-Free point of purchase visibility.
Michel is currently responsible for CMC and Clinical Supply at NOEMA Pharma, developing new central nervous system (CNS) therapies.
He is responsible for a portfolio covering 4 molecules and 6 ongoing trials Phase 2 a & b and entry into Phase3.
Michel has over 25 years of experience in Pharmaceutical Development, Manufacturing and Supply, at Roche, Aventis and in Biotech Start-ups.
Michel is a Chemical Engineer and holds an MBA from INSEAD.
Jamie Myers is a skilled and experienced pharmacist with a strong background in clinical research and inpatient hospital pharmacy operations. With a Pharm.D. from Saint Louis College of Pharmacy and a PGY-1 Residency from Duke University Medical Center, Jamie has a solid foundation in pharmaceutical knowledge and patient care.
Currently serving as Senior Manager of Global Clinical Supply Chain at Takeda, Jamie oversees the coordination and management of investigational oncology medication for phase I/2 research studies. Prior to this role, Jamie worked as a Clinical Research Pharmacist Specialist at Brigham and Women’s/Dana Farber Inpatient Hospital. There, she worked for investigational drug services and dispensed research medications for therapeutic areas like critical care, emergency room, oncology, neurology, dermatology, and rheumatoid arthritis. Jamie gained first-hand experience with gene therapy, viral vectors, and COVID-19 vaccines, and was involved in the design and implementation of clinical research studies.
Before joining Mass General Brigham, Jamie served as a Clinical Coordinator for Drug Trials at Maine Medical Center, where she handled both clinical research and pharmacy responsibilities. Jamie was responsible for dispensing, accountability, and advising for phase II through IV studies, and worked closely with CRAs for site evaluations, audits, and closeouts.
Jamie’s career also includes experience as a Pharmacy Operations Manager at Winchester Hospital and as a Medical Science Liaison (Clinical Science Manager) at Abbott. She has been involved in accelerated oncology programs, served as a preceptor for fellowship programs, and has been recognized as a subject matter expert in temperature excursions. Jamie has also contributed to various publications and research studies in the field of pharmacy.
With a strong commitment to patient care and research excellence, Jamie has demonstrated her ability to effectively manage clinical trials, collaborate with multidisciplinary teams, and ensure the highest standards of pharmaceutical care.
